Cargando…

Selective killing of p53-deficient cancer cells by SP600125

The genetic or functional inactivation of p53 is highly prevalent in human cancers. Using high-content videomicroscopy based on fluorescent TP53(+/+) and TP53(−/−) human colon carcinoma cells, we discovered that SP600125, a broad-spectrum serine/threonine kinase inhibitor, kills p53-deficient cells...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jemaà, Mohamed, Vitale, Ilio, Kepp, Oliver, Berardinelli, Francesco, Galluzzi, Lorenzo, Senovilla, Laura, Mariño, Guillermo, Malik, Shoaib Ahmad, Rello-Varona, Santiago, Lissa, Delphine, Antoccia, Antonio, Tailler, Maximilien, Schlemmer, Frederic, Harper, Francis, Pierron, Gérard, Castedo, Maria, Kroemer, Guido
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	WILEY-VCH Verlag 2012
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3443949/ https://www.ncbi.nlm.nih.gov/pubmed/22438244 http://dx.doi.org/10.1002/emmm.201200228

Ejemplares similares

An automated fluorescence videomicroscopy assay for the detection of mitotic catastrophe
por: Rello-Varona, S, et al.
Publicado: (2010)

Immunosurveillance against cancer-associated hyperploidy
por: Senovilla, Laura, et al.
Publicado: (2012)

Functions of BCL-X(L) at the Interface between Cell Death and Metabolism
por: Michels, Judith, et al.
Publicado: (2013)

An anticancer therapy-elicited immunosurveillance system that eliminates tetraploid cells
por: Senovilla, Laura, et al.
Publicado: (2013)

Tetraploid cancer cell precursors in ovarian carcinoma
por: Castedo, Maria, et al.
Publicado: (2012)

Inhibition of Chk1 Kills Tetraploid Tumor Cells through a p53-Dependent Pathway
por: Vitale, Ilio, et al.
Publicado: (2007)

Whole-genome duplication increases tumor cell sensitivity to MPS1 inhibition
por: Jemaà, Mohamed, et al.
Publicado: (2015)

Past, Present, and Future of Molecular and Cellular Oncology
por: Galluzzi, Lorenzo, et al.
Publicado: (2011)

Antiapoptotic activity of argon and xenon
por: Spaggiari, Sabrina, et al.
Publicado: (2013)

Cell Death Signaling and Anticancer Therapy
por: Galluzzi, Lorenzo, et al.
Publicado: (2011)

Trial Watch: Proteasomal inhibitors for anticancer therapy
por: Obrist, Florine, et al.
Publicado: (2014)

Chloroquine and hydroxychloroquine for cancer therapy
por: Manic, Gwenola, et al.
Publicado: (2014)

Immunogenic cell death inducers as anticancer agents
por: Kepp, Oliver, et al.
Publicado: (2014)

Novel galenic formulations for delivering immunochemotherapies: kill intelligently, remove the checkpoint and let the T cells in!
por: Kepp, Oliver, et al.
Publicado: (2020)

TP53 and MTOR crosstalk to regulate cellular senescence
por: Galluzzi, Lorenzo, et al.
Publicado: (2010)

Immunogenic cell death in radiation therapy
por: Galluzzi, Lorenzo, et al.
Publicado: (2013)

Immune effectors required for the therapeutic activity of vorinostat
por: Kepp, Oliver, et al.
Publicado: (2013)

Mitochondrial regulation of cell death: a phylogenetically conserved control
por: Galluzzi, Lorenzo, et al.
Publicado: (2016)

Oncosuppressive functions of PIDD1 in response to centrosome amplification
por: Vitale, Ilio, et al.
Publicado: (2021)

Erratum to Martins I, et al. Cell Cycle Volume 8, Issue 22; pp. 3723–8
por: Martins, Isabelle, et al.
Publicado: (2012)

A mitochondrial checkpoint to adaptive anticancer immunity
por: Kepp, Oliver, et al.
Publicado: (2023)

Screening of novel immunogenic cell death inducers within the NCI Mechanistic Diversity Set
por: Sukkurwala, Abdul Qader, et al.
Publicado: (2014)

Systems biology of cisplatin resistance: past, present and future
por: Galluzzi, L, et al.
Publicado: (2014)

SP600125 Induces Src and Type I IGF Receptor Phosphorylation Independent of JNK
por: Kong, Qingbin, et al.
Publicado: (2014)

Characteristics of SP600125 Induced Tetraploid Cells in Comparison With Diploid and Tetraploid Cells of Fish
por: Fan, Yunpeng, et al.
Publicado: (2021)

Trial Watch: Anticancer radioimmunotherapy
por: Vacchelli, Erika, et al.
Publicado: (2013)

SP600125 has a remarkable anticancer potential against undifferentiated thyroid cancer through selective action on ROCK and p53 pathways
por: Grassi, Elisa Stellaria, et al.
Publicado: (2015)

Autotetraploid cell Line induced by SP600125 from crucian carp and its developmental potentiality
por: Zhou, Yonghua, et al.
Publicado: (2016)

Effect of JNK inhibitor SP600125 on hair cell regeneration in zebrafish (Danio rerio) larvae
por: He, Yingzi, et al.
Publicado: (2016)

Independent transcriptional reprogramming and apoptosis induction by cisplatin
por: Galluzzi, Lorenzo, et al.
Publicado: (2012)

Immunogenic cell death in cancer: concept and therapeutic implications
por: Galluzzi, Lorenzo, et al.
Publicado: (2023)

NBN Gene Polymorphisms and Cancer Susceptibility: A Systemic Review
por: Berardinelli, Francesco, et al.
Publicado: (2013)

Effect of SP600125 on the mitotic spindle in HeLa Cells, leading to mitotic arrest, endoreduplication and apoptosis
por: Mili, Donia, et al.
Publicado: (2016)

Protective effects of SP600125 on mice infected with H1N1 influenza A virus
por: Tang, Yuling, et al.
Publicado: (2021)

Trial watch: Dendritic cell-based interventions for cancer therapy
por: Vacchelli, Erika, et al.
Publicado: (2013)

A New Method for Chromosomes Preparation by ATP-Competitive Inhibitor SP600125 via Enhancement of Endomitosis in Fish
por: Xu, Wenting, et al.
Publicado: (2021)

Trial watch: Chemotherapy with immunogenic cell death inducers
por: Vacchelli, Erika, et al.
Publicado: (2013)

Chemosensitization strategies for the treatment of lung cancer
por: Senovilla, Laura, et al.
Publicado: (2015)

Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signalling
por: Ko, A, et al.
Publicado: (2014)

By reducing global mRNA translation in several ways, 2-deoxyglucose lowers MCL-1 protein and sensitizes hemopoietic tumor cells to BH3 mimetic ABT737
por: Tailler, Maximilien, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ov52vlcg6o25oit6h7j4rsnkl5